<DOC>
	<DOCNO>NCT02951702</DOCNO>
	<brief_summary>The purpose study determine oral vancomycin use primary Clostridium difficile prophylaxis reduce incidence infection high-risk patient .</brief_summary>
	<brief_title>Oral Vancomyin Primary Clostridium Difficile Infection Prophylaxis Patients Receiving High-Risk Antibiotics</brief_title>
	<detailed_description>Clostridium difficile infection common healthcare-associated infection one associate significant morbidity well risk mortality . Current practice throughout United States target infection prevention measure hand wash isolation . Despite measure , incidence Clostridium difficile infection continue rise institution , include . Recently , study publish Clinical Infectious Diseases find oral vancomycin secondary prophylaxis reduce incidence recurrence . No study date evaluate primary prophylaxis oral vancomycin . This single center , prospective study evaluate oral vancomycin use primary Clostridium difficile prophylaxis . Patients treat infectious disease physician identify `` high risk '' pager notification ID physician option start oral vancomycin 125 mg mouth daily determine appropriate . Risk factor include age old 65 year , take gastric acid suppression medication , receive select broad-spectrum antibiotic . Oral vancomycin continue de-escalation antibiotic hospital discharge patient evaluate Clostridium difficile infection development current hospital admission 4 week follow antibiotic discontinuation .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>`` Highrisk '' patient define : age old 65 , gastric acid suppression , select antibiotic Gastric acid suppression include proton pump inhibitor histamine2 receptor antagonist Selected antibiotic include fluoroquinolone ( ciprofloxacin , levofloxacin ) , clindamycin , 3rd 4th generation cephalosporin , broadspectrum aminopenicillin ( ampicillinsulbactam , piperacillintazobactam ) , carbapenem Failure meet three requirement `` high risk '' Vancomycin allergy Active clostridium difficile infection prior inclusion Prophylactic oral vancomycin prior study inclusion ( i.e . prolonged vancomycin taper ) Receipt medication also treat Clostridium difficile ( metronidazole , rifaximin , fidaxomicin ) Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>